Assembly Actions -
Lowercase Senate Actions - UPPERCASE |
|
---|---|
Jan 03, 2018 |
referred to health |
Mar 06, 2017 |
referred to health |
Assembly Bill A6390
2017-2018 Legislative Session
Sponsored By
WALKER
Archive: Last Bill Status - In Assembly Committee
- Introduced
-
- In Committee Assembly
- In Committee Senate
-
- On Floor Calendar Assembly
- On Floor Calendar Senate
-
- Passed Assembly
- Passed Senate
- Delivered to Governor
- Signed By Governor
Actions
co-Sponsors
Felix Ortiz
Aileen Gunther
Rebecca Seawright
Angelo Santabarbara
2017-A6390 (ACTIVE) - Details
- See Senate Version of this Bill:
- S2193
- Current Committee:
- Assembly Health
- Law Section:
- Health, Commissioner of
- Versions Introduced in Other Legislative Sessions:
-
2009-2010:
S8202
2011-2012: S1172
2013-2014: S3100
2015-2016: A6785, S2761
2019-2020: A3439, S2599
2021-2022: A4527, S3167
2023-2024: A1969, S4677
2017-A6390 (ACTIVE) - Bill Text download pdf
S T A T E O F N E W Y O R K ________________________________________________________________________ 6390 2017-2018 Regular Sessions I N A S S E M B L Y March 6, 2017 ___________ Introduced by M. of A. WALKER -- read once and referred to the Committee on Health AN ACT authorizing and directing the department of health to do research and study as to the effects of psychostimulants, selective seratonin reuptake inhibitors, antidepressants and other drugs which are prescribed for attention deficit disorders, ADD and ADHD, for school age children THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM- BLY, DO ENACT AS FOLLOWS: Section 1. 1. The commissioner of health, in conjunction with the commissioner of mental health, the commissioner of developmental disa- bilities, and the commissioner of education is authorized and directed to conduct a study and do research as to the effect of psychostimulants, selective serotonin reuptake inhibitors, antidepressants and other drugs prescribed for attention deficit disorder, attention deficit hyperactiv- ity disorder, and the increasing rate of diagnosis of these conditions, in school age children. 2. The study shall be conducted in accordance with rules, regulations and standards determined by the commissioner of health, and the study shall concentrate on harmful side effects of such drugs, the appropri- ateness and effectiveness of tools and methods used to assess and diag- nose the condition, the appropriateness of different medications, and any demographic disparities in diagnosis. 3. The commissioner of health shall report his or her findings to the governor, the speaker of the assembly and the temporary president of the senate on or before two years from the date this act shall take effect. ยง 2. This act shall take effect immediately. EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets [ ] is old law to be omitted. LBD06179-01-7
Comments
Open Legislation is a forum for New York State legislation. All comments are subject to review and community moderation is encouraged.
Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity, hate or toxic speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Attempts to intimidate and silence contributors or deliberately deceive the public, including excessive or extraneous posting/posts, or coordinated activity, are prohibited and may result in the temporary or permanent banning of the user. Comment moderation is generally performed Monday through Friday. By contributing or voting you agree to the Terms of Participation and verify you are over 13.
Create an account. An account allows you to sign petitions with a single click, officially support or oppose key legislation, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.